{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-066656","form_type":"8-K","ticker":"RCEL","cik":"0001762303","company_name":"AVITA Medical, Inc.","filed_at":"2024-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.956957+00:00","generated_at":"2026-06-01T07:26:41.712365+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"AVITA Medical receives FDA approval for RECELL GO next-gen skin harvesting device","bullets":["FDA approved RECELL GO next-gen autologous cell harvesting device for thermal burn wounds and full-thickness skin defects.","Device reduces training burden, improves OR workflow, and controls enzyme incubation for optimal cell yield; launch June 2024.","Clinical benefits: uses less donor skin, reduces pain, speeds closure, cuts procedures, shortens hospital stays for burns <50% TBSA."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-066656","json":"https://secwatch.observer/filing/0000950170-24-066656.json","markdown":"https://secwatch.observer/filing/0000950170-24-066656.md","text":"https://secwatch.observer/filing/0000950170-24-066656.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1762303/000095017024066656/0000950170-24-066656-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1762303/000095017024066656/rcel-20240529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:26:41.712365+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}